Goldman Sachs Group Inc Enochian Biosciences Inc Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 306,144 shares of ENOB stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
306,144
Previous 12,871
2278.56%
Holding current value
$1.41 Million
Previous $59,000
2286.44%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ENOB
# of Institutions
43Shares Held
7.25MCall Options Held
16KPut Options Held
12.5K-
Vanguard Group Inc Valley Forge, PA3.92MShares$18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$2.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY375KShares$1.73 Million0.0% of portfolio
-
Black Rock Inc. New York, NY314KShares$1.45 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny294KShares$1.35 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...